|Last Update: 05/17/13 - 4:00 PM EDT|
|YTD Performance: -16.58%|
|Previous Close: $18.62|
|52 Week Range: $18.00 - $25.89|
|Oustanding Shares: 317,750,908|
|Market Cap: 5,916,521,907|
|Qtr (06/13)||Qtr (09/13)||FY (09/13)||FY (09/14)|
|Number of Analysts||7||7||7||7|
|Growth Rate (Year over Year)||-39.83%||-31.17%||-46.91%||11.46%|
Here's how some current events and attitudes line up with Buffett's philosophy.
Amid all the bluster and flow of earnings, some perspective is needed.
NUAN was downgraded to Equal-weight, Morgan Stanley said. Company is facing increased growth risks.
I’ve found a number of confirming data points for these stocks.
These two inexpensive stocks will likely also benefit from this renowned investor advocate's activism.
These stocks all pique my interest at current levels.
A bullishly-biased, longer-term options strategy in this voice and language solution innovator.
NUAN was downgraded from Buy to Hold, Needham said. Company is seeing lower international sales and demand from healthcare customers.
The vast majority of the company is a medical transcription business.